abdominal aortic aneurysm with massive aortic atheroma
Conditions
Interventions
Pitavastatin 1mg
Pitavastatin 4mg
Sponsors
The University of Tokyo Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients with abdominal aortic aneurysm/ iliac aneurysm which have massive aortic atheroma, who fulfill the item (1) to (4) shown below. (1) patients with massive atheroma (a) from left subclavian artery to renal artery more than half of circumstances, more than 5 mm in thickness, and more than 3 cm in length (b) aneurysmal neck more than 3/4 of circumstances, more than 5 mm in thickness, and more than 5 mm in length (2) patients who need lipid-lowering therapy (3) patients who are scheduled to perform aneurysm repair (4) Renal function: CKD 1 to 3
Exclusion criteria
Exclusion criteria: (1) patients who have already prescribed statin (2) Renal function: CKD 4 and 5 (3) pregnancy (4) severe liver dysfunction (5) patients who have had drugs of contraindication (6) patients of whom the clinical investigator judged as inappropriate for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of atheroma volume | — |
Secondary
| Measure | Time frame |
|---|---|
| Complications after abdominal aortic aneurysm repair | — |
Countries
Japan
Contacts
Public ContactKatsuyuki Hoshina
The University of Tokyo Hospital Vascular Surgery
Outcome results
None listed